Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
12 Leser
Artikel bewerten:
(0)

Global ENT and Bronchoscopy Devices Market Expected to Reach $24,999 Million by 2022 - Allied Market Research

PORTLAND, Oregon and PUNE, India, March 17, 2017 /PRNewswire/ --

ENT & bronchoscopy devices market was valued at $14,476 million in 2015, and is projected to reach $24,999 million by 2022, growing at a CAGR of 8.1% from 2016 to 2022, According to a new report published by Allied Market Research. The hearing care devices segment accounted for more than two-fifths of the total market in 2015.

(Logo: http://photos.prnewswire.com/prnh/20140911/647229 )

Smelling disorders, hearing disorders as well as problems associated with speaking or snoring are rectified by ENT devices. The complete airway of a patient including lungs and alveoli is examined via bronchoscopy. Both ENT & bronchoscopy devices assist otolaryngologists for the treatment of patients suffering from disorders of ear, nose, throat, and related structures of the head & neck.

Get access to detailed report at: https://www.alliedmarketresearch.com/ent-and-bronchoscopy-market

The market is driven by high incidence of hearing and nasal disorders, new technological advancements in ENT & bronchoscopy devices, growth in geriatric population, and increase in patient preference for minimally invasive procedures. However, this growth is limited by high cost of these devices (especially in developing nations) and lack of skilled professionals. The demand for cosmetic ENT procedures and emerging markets in Asia-Pacific and LAMEA are expected to provide several opportunities for key players.

Hearing care devices is expected to maintain its dominant position throughout the analysis period, due to increase in incidence of hearing disorders and technological innovations in hearing devices, such as development of miniature hearing aids, anti-inflammatory drug-releasing cochlear implants, and auditory brainstem implants.

Surgical ENT & bronchoscopy devices segment is expected to grow at the highest CAGR of 12.5% in the future, owing to increased demand for radiofrequency devices, balloon sinus dilation devices, and ENT lasers.

According to Hemali Narkhede, Manager, Healthcare Research at Allied Market Research, "There have been revolutionary advancements in ENT & bronchoscopy devices, such as development of smaller hearing aids that are not visible from outside. This has increased the adoption of hearing aids among patients as well as healthcare providers." she further added.

Key findings of ENT & bronchoscopy devices market:

  • Based on product type, hearing care devices segment accounted for more than two-fifths of the total market in 2015.
  • Flexible endoscopes accounted for nearly two-fifths of the ENT endoscopes market in 2015.
  • Balloon sinus dilation devices segment is expected to grow at the highest CAGR of 16.5%, as the device provides a minimally invasive approach for the treatment of distorted/blocked sinus pathway.
  • Hospitals & clinics accounted for nearly half of the total market share in 2015.
  • Asia-Pacific is expected grow at a high CAGR of 9%, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of ENT disorders.

North America accounted for majority of the share (nearly one-third) in the market in 2015, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of nasal and hearing disorders along with the rise in geriatric population, increased patient awareness about the availability of treatment options, and favorable reimbursement framework for ENT procedures. In addition, the high adoption rate of technologically advanced devices and presence of highly sophisticated healthcare infrastructure are anticipated to provide new growth opportunities for the key players in this market.

The major companies profiled in the report include Karl Storz Gmbh & Co. Kg, Medtronic PLC, Smith & Nephew PLC, Olympus Corporation, Johnson & Johnson (Acclarent, Inc.), Cochlear Limited, Hoya Corporation (Pentax medical), Sonova Holding AG, William Demant Holding A/S, Entellus Medical, Inc., MED-EL, Sivantos Pte. Ltd. and GN Store Nord A/S.

Read more about this research into the Medical Devices market: https://www.alliedmarketresearch.com/life-sciences/medical-devices-market-report

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Rahul Thakur
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1-(855)-550-5975
E-mail: sales@alliedmarketresearch.com

Website: https://www.alliedmarketresearch.com


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.